Accepted (ET)
7:14 AM
Sep 21, 2026
Filed
Sep 21, 2026
Documents
15
Size
446.7 KB
Summary
Avantor, Inc. Appoints Todd Garner as CFO
What Happened
Avantor, Inc. announced the appointment of Todd Garner as Executive Vice President and Chief Financial Officer, effective September 21, 2026. The company entered into an employment letter dated September 17, 2026. Mr. Garner, age 57, joins from CONMED (CFO, Jan 2018–Mar 2026) and previously held various finance roles at C.R. Bard from 2003–2017. Upon his start, Steven Eck will stop serving as Interim CFO and continue as Senior Vice President and Chief Accounting Officer. A press release announcing the appointment is furnished as Exhibit 99.1.
Key Details
- Start date: September 21, 2026; employment letter dated September 17, 2026.
- Pay & bonus: Annual base salary $700,000; annual target cash bonus 80% of base (pro‑rated for 2026).
- Sign-on & equity: $150,000 one‑time cash signing bonus (subject to repayment if he departs within one year). Initial equity grant target $1,500,000 — half restricted stock units (vest ratably over 2 years) and half stock options (granted at a 10% premium; vest ratably over 3 years).
- Ongoing incentives & protections: Eligible for future long‑term incentive grants with a target of $3,000,000 annually (aligned with other Executive Leadership Team members) and participation in the company’s Executive Severance and Change in Control Plan.
- Conflicts: Company states there are no arrangements, family relationships, or related‑party transactions requiring disclosure under Item 404(a) of Regulation S‑K.
Why It Matters
This filing formalizes a permanent CFO hire to replace an interim finance leader, which is a key leadership change for investors monitoring Avantor’s financial strategy and execution. The compensation package—cash salary, sizable equity awards, and severance/change‑in‑control participation—signals the company’s intent to retain and align Mr. Garner with long‑term performance. Investors should note the timing (effective Sept 21, 2026) and the structure of equity vesting when assessing potential dilution timing and executive incentives.